Last reviewed · How we verify

NCT04162496

Restylane Refyne for Correction of Horizontal Neck Rhytides

Active, enrolled NA Last updated 8 June 2021
What this trial tests

NA trial testing Restylane Refyne in Aging in 24 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
11 August 2020
Primary endpoint
22 January 2021
30 September 2021

Quick facts

Lead sponsorSiperstein Dermatology
PhaseNA
StatusActive, enrolled
Study typeINTERVENTIONAL
Allocationrandomized
Designsingle group
Maskingsingle
Primary purposetreatment
Enrollment24
Start date11 August 2020
Primary completion22 January 2021
Estimated completion30 September 2021
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Siperstein Dermatology

Who can join

18 and older, any sex, with Aging or Wrinkle. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Subjects with grades ranging from 1---3 on the Transverse Neck Line Scale, will be randomized to receive up to 1cc of Restylane Refyne on one side of their neck utilizing a cannula and up to 1cc of Restylane Refyne on the other side utilizing a 30--gauge needle. On Day 30, this treatment with the same left---right assignment can be repeated if optimal correction on either side has not been achieved according to the treating investigator. Subjects will return 24--48 hours after their first treatment, to fill out questionnaires, take pictures, and to be assessed by blinded evaluators regarding adverse events. Subjects will also return 30 days after their final treatment to fill out final questionnaires, take pictures, and to be assessed by blinded evaluators regarding improvement of static rhytides.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. One-Year Data on the Longevity and Safety of Hyaluronic Acid Filler for Static Horizontal Neck Rhytids.
    Siperstein R, Nestor E, Meran S, Grunebaum L, et al · · 2023 · cited 2× · PMID 37738217 · DOI 10.1097/dss.0000000000003920

Verify or expand the search:

Other recruiting trials for Aging

Currently open trials in the same condition.

Other Siperstein Dermatology trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04162496.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing